I think the key point is that at the end of each trading session we know (subject to the veracity of data reported to ASIC each day) those shorts remaining (ie the amount of overhang in the stock) and which ultimately will need to be covered at some point by short sellers purchasing shares.
As that short selling position increases which has happened up until recently in the case of CU6 (and unfortunately the 4 day lag for reporting net shorts creates uncertainty in this regard), regardless of whether its an increased exposure by the same short sellers, or by an increasing number of short sellers who may have different trading tactics, ulrimately the exposure becomes increasingly harder to close out.
With the share price decline of CU6 now stalling, and the likelihood of further large share price declines lessened, IMO the shorts are becoming increasingly vulnerable -especially with a quarterly report due by the end of next week (and yes that report could contain good or bad news).
- Forums
- ASX - By Stock
- CU6 - ASX Charts
CU6
clarity pharmaceuticals ltd
Add to My Watchlist
5.44%
!
$2.52

I think the key point is that at the end of each trading session...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.52 |
Change
0.130(5.44%) |
Mkt cap ! $810.1M |
Open | High | Low | Value | Volume |
$2.39 | $2.54 | $2.37 | $5.141M | 2.072M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 6820 | $2.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.52 | 3500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 405 | 2.500 |
1 | 20000 | 2.480 |
4 | 41204 | 2.450 |
1 | 5000 | 2.410 |
5 | 3695 | 2.400 |
Price($) | Vol. | No. |
---|---|---|
2.520 | 3500 | 1 |
2.540 | 37102 | 3 |
2.550 | 30520 | 6 |
2.580 | 30000 | 2 |
2.590 | 10004 | 2 |
Last trade - 16.17pm 27/06/2025 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online